Who is sponsoring NCT02392754?

NCT02392754 is sponsored by Population Health Research Institute.

What condition does NCT02392754 study?

NCT02392754 studies Atrial Fibrillation, Hypertension.

Is NCT02392754 still recruiting?

NCT02392754 is currently completed. Last updated 27 January 2020.

Last reviewed 2020-01-27 · How we verify

NCT02392754: SCREEN-AF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Home-Based Screening for Early Detection of Atrial Fibrillation in Primary Care Patients Aged 75 Years and Older

Completed NA Last updated 27 January 2020

What this trial tests

NA trial testing Screening: Intervention - Atrial fibrillation screening (ZIO XT ECG monitor, Watch-BP) in Atrial Fibrillation in 856 participants. Completed in 21 January 2020.

Timeline

1 April 2015

Primary endpoint
21 October 2019

21 January 2020

Quick facts

Lead sponsor	Population Health Research Institute
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	856
Start date	1 April 2015
Primary completion	21 October 2019
Estimated completion	21 January 2020
Sites	28 locations across Canada, Germany

Drugs / interventions tested

Screening: Intervention - Atrial fibrillation screening (ZIO XT ECG monitor, Watch-BP)

Conditions studied

Atrial Fibrillation — all drugs for Atrial Fibrillation →
Hypertension — all drugs for Hypertension →

Sponsor

Population Health Research Institute

Who can join

75 and older, any sex, with Atrial Fibrillation or Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Atrial fibrillation (AF) is a major treatable risk factor for stroke, but it may be hard to detect because it is frequently silent and intermittent. New ambulatory cardiac monitoring technologies have the potential to improve early detection of AF. This trial investigates AF screening in primary care patients using the ZIO XT Patch, a wearable adhesive patch monitor that provides continuous ECG recording for up to 14 days, in addition to the WatchBP home blood pressure monitor that has built-in AF screening capability.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Atrial fibrillation: epidemiology, screening and digital health.
Linz D, Gawalko M, Betz K, Hendriks JM, et al · · 2024 · cited 230× · PMID 38362546 · DOI 10.1016/j.lanepe.2023.100786
Screening for Atrial Fibrillation in the Older Population: A Randomized Clinical Trial.
Gladstone DJ, Wachter R, Schmalstieg-Bahr K, Quinn FR, et al · · 2021 · cited 147× · PMID 33625468 · DOI 10.1001/jamacardio.2021.0038
Review of mobile applications for the detection and management of atrial fibrillation.
Turchioe MR, Jimenez V, Isaac S, Alshalabi M, et al · · 2020 · cited 13× · PMID 32656542 · DOI 10.1016/j.hroo.2020.02.005
Biomarkers for predicting atrial fibrillation: An explorative sub-analysis of the randomised SCREEN-AF trial.
Schmalstieg-Bahr K, Gladstone DJ, Hummers E, Suerbaum J, et al · · 2024 · cited 9× · PMID 38497412 · DOI 10.1080/13814788.2024.2327367
Understanding the Burden of Atrial Fibrillation and Importance of Screening: A Global Perspective and Recommendations for Turkey.
Aras D, Birgül E, Görenek B, Gürkaş E, et al · · 2022 · cited 6× · PMID 35949120 · DOI 10.5152/anatoljcardiol.2022.1689

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting

Other Population Health Research Institute trials

Trials by the same sponsor.

NCT07511543 — Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy · Phase 2 · not yet recruiting
NCT07468448 — Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in IntraCranial Atherosclerotic diseaSe · Phase 3 · not yet recruiting
NCT06587737 — Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage · Phase 3 · not yet recruiting
NCT07011095 — DOAC or VKA in Patients With AF and Stroke While on DOAC - a Pilot Trial · EARLY_PHASE1 · not yet recruiting
NCT06508164 — International CRDS Registry · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02392754 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Population Health Research Institute
Last refreshed: 27 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02392754.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing